DEC 03, 2020 6:00 AM PST

Spit Contains Concussion Clues

WRITTEN BY: Tara Fernandez

Drowsiness, confusion, headaches, and sensitivity to light — it’s sometimes hard for doctors to spot the signs of a concussion based on the symptoms alone. Typically, CT or MRI head scans are ordered by physicians after a physical examination, but even these tests don’t always get it right. As a consequence, experts agree that concussion diagnoses are confusing for both neurologists and patients alike.

New research from the Penn State College of Medicine has revealed that molecules in saliva could help diagnose this traumatic brain injury in a non-invasive and non-biased way, cutting through this confusion.

Scientists obtained spit samples from a cohort of over 500 individuals and analyzed them, searching for microRNAs — tiny non-coding RNA molecules, each around 22 nucleotides in length. Cells use microRNAs to control the expression of genes, and these short fragments of genetic material are found in abundance inside cells, in the bloodstream, and, importantly, in the brain.

According to the scientists, microRNA levels present in the saliva could be altered after a concussion as there is a network of cranial nerves inside the oral cavity.

“Current methods rely on accurate symptom reporting and honest performance on neurocognitive testing,” said study lead Steve Hicks, associate professor of pediatrics. “Analyzing microRNA profiles in saliva following a head trauma is a non-invasive way to test for concussion that can’t be influenced by a patient’s feelings or motives.”

Around half of the study’s participants had reported a positive concussion diagnosis during the investigation, while the undiagnosed patients displayed symptoms such as fatigue and headaches, which could point towards the possibility of head trauma.

The scientists mapped the RNA profiles within saliva samples using sequencing technologies, creating a blueprint for what concussion-related microRNA changes look like. They then developed this into a diagnostic test, which successfully picked up concussions in 200 additional study participants.

“This method has lots of promising applications,” said Hicks. “A rapid, reliable diagnostic means that early, appropriate action can be taken to alleviate the symptoms of patients with concussions.”

A “spit test” diagnostic device for concussions would fast track clinical interventions for brain injuries, particularly for emergency first responders and for athletes.

 

 

Sources: Clinical and Translational Medicine, Penn State Health News.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 02, 2020
Clinical & Molecular DX
Digital Platform Watches for a Silent COVID Killer
DEC 02, 2020
Digital Platform Watches for a Silent COVID Killer
 
DEC 16, 2020
Clinical & Molecular DX
Gene Marker PACS a Punch for Cervical Cancer Treatments
DEC 16, 2020
Gene Marker PACS a Punch for Cervical Cancer Treatments
In cervical cancer, mutations in healthy cells cause cells to grow and multiply uncontrollably, invading surrounding tis ...
JAN 24, 2021
Genetics & Genomics
Rare Neurodevelopment Disorder LINKED is IDed
JAN 24, 2021
Rare Neurodevelopment Disorder LINKED is IDed
Scientists have now characterized a genetic disorder called linkage-specific-deubiquitylation-deficiency-induced embryon ...
JAN 26, 2021
Cell & Molecular Biology
Diagnostic Tool Could ID 20% of Autism Cases
JAN 26, 2021
Diagnostic Tool Could ID 20% of Autism Cases
Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disord ...
FEB 02, 2021
Immunology
Pumping the Brakes on Stomach Cancer Progression
FEB 02, 2021
Pumping the Brakes on Stomach Cancer Progression
By the time stomach cancer is diagnosed, it’s often bad news for patients. The disease often presents with relativ ...
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
Loading Comments...